http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106265621-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
filingDate | 2016-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106265621-B |
titleOfInvention | Dimethyl fumarate prevents and treats the application in graft versus host disease(GVH disease) and Graft versus leukemia drug in preparation |
abstract | A kind of purposes of pharmaceutical composition the present invention relates to dimethyl fumarate or containing dimethyl fumarate in medicine preparation, the drug is for preventing and treating the acute graft versus host disease after Allogeneic Hematopoietic Stem Cell Transplantation.The present invention has found that dimethyl fumarate has the function of significantly inhibiting acute graft versus host disease by animal experiment study, can be used to prepare the drug for preventing and treating graft versus host disease(GVH disease) and Graft versus leukemia. |
priorityDate | 2016-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.